<p class="Section amending&#xA;        "><strong><a id="s-9."><span class="sectionLabel">9.</span></a></strong> The Act is amended by adding the following after section 31.1:</p><section><div class="AmendedText"><h6 class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Offences relating to therapeutic products</h6><p class="Section"><strong>31.2</strong> Subject to section 31.4, every person who contravenes any provision of this Act or the regulations, as it relates to a therapeutic product, or an order made under any of sections 21.1 to 21.3 is guilty of an offence and liable</p><ul class="ProvisionList"><li><p class="Paragraph">(<em>a</em>) on conviction by indictment, to a fine not exceeding $5,000,000 or to imprisonment for a term not exceeding two years or to both; and</p></li><li><p class="Paragraph">(<em>b</em>) on summary conviction, for a first offence, to a fine not exceeding $250,000 or to imprisonment for a term not exceeding six months or to both and, for a subsequent offence, to a fine not exceeding $500,000 or to imprisonment for a term not exceeding 18 months or to both.</p></li></ul><h6 class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Due diligence</h6><p class="Section"><strong>31.3</strong> Due diligence is a defence in a prosecution for an offence under this Act, other than an offence under section 31.4.</p><h6 class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Offences — section 21.6 and serious risk</h6><p class="Section"><strong>31.4</strong> A person who contravenes section 21.6, or who knowingly or recklessly causes a serious risk of injury to human health in contravening another provision of this Act or the regulations, as it relates to a therapeutic product, or an order made under any of sections 21.1 to 21.3 is guilty of an offence and liable</p><ul class="ProvisionList"><li><p class="Paragraph">(<em>a</em>) on conviction on indictment, to a fine the amount of which is at the discretion of the court or to imprisonment for a term not exceeding five years or to both; and</p></li><li><p class="Paragraph">(<em>b</em>) on summary conviction, for a first offence, to a fine not exceeding $500,000 or to imprisonment for a term not exceeding 18 months or to both and, for a subsequent offence, to a fine not exceeding $1,000,000 or to imprisonment for a term not exceeding two years or to both.</p></li></ul><h6 class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Sentencing considerations</h6><p class="Section"><strong>31.5</strong> A court that imposes a sentence for an offence under section 31.2 or 31.4 shall take into account, in addition to any other principles that it is required to consider, the following factors:</p><ul class="ProvisionList"><li><p class="Paragraph">(<em>a</em>) the harm or risk of harm caused by the commission of the offence; and</p></li><li><p class="Paragraph">(<em>b</em>) the vulnerability of consumers of the therapeutic product.</p></li></ul><h6 class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Parties to offence</h6><p class="Section"><strong>31.6</strong> If a person other than an individual commits an offence under section 31.2, or commits an offence under section 31.4 by reason of contravening section 21.6, then any of the person’s directors, officers or agents or mandataries who directs, authorizes, assents to or acquiesces or participates in the commission of the offence is a party to the offence and is liable on conviction to the punishment provided for by this Act, even if the person is not prosecuted for the offence.</p><h6 class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Continuing offence</h6><p class="Section"><strong>31.7</strong> If an offence under section 31.2 or 31.4 is committed or continued on more than one day, it constitutes a separate offence for each day on which it is committed or continued.</p></div></section>
